Jatenzo Cost in Georgia 2026: Cash Price, Insurance, and Savings Options

What Is the Cash Price of Jatenzo in Georgia in 2026?

The retail cash price for Jatenzo in Georgia sits at approximately $900 per month in 2026, matching the manufacturer's list price set by Tolmar Pharmaceuticals. No major Georgia retail chain has reported generic competition because no generic oral testosterone undecanoate capsule has received FDA approval as of this writing. Prices at independent Georgia pharmacies, mail-order pharmacies, and large chains (CVS, Walgreens, Kroger) are broadly consistent at that $900 level without assistance programs.

That figure covers a standard monthly supply of 158 mg capsules taken twice daily with a meal. The FDA-approved dose range is 158 mg to 396 mg twice daily, titrated to morning serum testosterone levels drawn two to eight hours after the morning dose. A higher titrated dose therefore increases the monthly capsule count and the corresponding cost. Patients prescribed 237 mg twice daily, for example, require more capsules per fill and may see costs approach $1,100 to $1,200 per month at list price before any discount.

GoodRx and similar coupon aggregators list Jatenzo in the $820 to $910 range at Georgia zip codes in early 2026, but those coupons cannot be combined with insurance and are not accepted at all pharmacy chains. Confirm coupon acceptance before presenting at the counter.

The Endocrine Society's 2018 Clinical Practice Guideline on testosterone therapy states: "We suggest using formulations that maintain serum testosterone levels within the normal range and are associated with the fewest side effects and the lowest cost burden to the patient." [1] Cost is therefore a guideline-recognized clinical variable, not merely a financial preference.

Swerdloff et al. (J Clin Endocrinol Metab 2020, N=166) demonstrated that 87% of hypogonadal men reached average testosterone levels in the normal range (300 to 1 to 000 ng/dL) at the titrated dose over 90 days, establishing the pharmacokinetic profile that the FDA used to support approval. [2] The FDA prescribing information for Jatenzo is accessible via the FDA's Drugs@FDA database. [3]

Does Georgia Medicaid Cover Jatenzo?

Georgia Medicaid does not cover Jatenzo for the treatment of male hypogonadism. The Georgia Department of Community Health Preferred Drug List (PDL) includes oral testosterone undecanoate (Jatenzo) only under the diabetes/cardiovascular therapeutic category, specifically for adults with type 2 diabetes who meet additional glycemic criteria. [4] A man seeking Jatenzo solely for hypogonadism, low testosterone, or age-related testosterone decline will be denied under Georgia Medicaid without an approved exception.

This restriction aligns with the FDA's black-box warning on Jatenzo regarding blood pressure elevation, which limits its indicated use and complicates formulary placement. [3] Georgia Medicaid's preferred agents for testosterone replacement in hypogonadism are intramuscular testosterone cypionate and testosterone enanthate, both available as generics at minimal cost through Medicaid.

Prior authorization exception requests citing documented primary hypogonadism (Klinefelter syndrome, bilateral orchiectomy, radiation-induced failure) have a higher, though not guaranteed, approval rate. A Georgia Medicaid prior authorization form citing ICD-10 code E29.1 along with two documented serum testosterone values below 300 ng/dL drawn at least 30 days apart, each confirmed before 10:00 a.m., gives the strongest clinical foundation for an appeal.

A 2023 JAMA Internal Medicine analysis of testosterone prescribing in Medicaid programs found that injectable formulations accounted for 78% of all testosterone prescriptions in state Medicaid programs, reflecting the formulary economics that keep oral branded agents like Jatenzo off most state preferred drug lists. [5]

Which Private Insurance Plans Cover Jatenzo in Georgia?

Coverage varies widely. Most large commercial carriers operating in Georgia, including Blue Cross Blue Shield of Georgia, Aetna, Cigna, and UnitedHealthcare, place Jatenzo on Tier 3 or Tier 4 specialty formulary positions. Prior authorization is nearly universal across these plans. Standard PA criteria require:

• At least two morning serum testosterone levels below 300 ng/dL (or the plan's stated threshold), drawn on separate days
• A diagnosis consistent with an FDA-approved indication (primary hypogonadism or hypogonadotropic hypogonadism)
• Documentation that at least one lower-cost testosterone formulation was trialed or is clinically contraindicated

After meeting PA criteria, patient out-of-pocket costs range from $50 to $300 per month depending on the specific plan's cost-sharing structure. Employer-sponsored high-deductible health plans often require the patient to meet the full deductible before any cost-sharing kicks in, which can mean one or two months at list price before the plan contribution begins.

The American Urological Association's 2023 guideline update on male hypogonadism emphasizes individualized treatment selection and acknowledges that "route of administration preferences and formulary access are legitimate determinants of therapy choice." [6] That language is useful when writing a letter of medical necessity to support a PA or appeal.

Georgia-specific exchange plans (ACA marketplace) follow similar tier structures. Check your specific Summary of Benefits and Coverage document for the formulary tier and step-therapy requirements before assuming coverage.

How Does the Tolmar Jatenzo Savings Card Work in Georgia?

Tolmar Pharmaceuticals offers a co-pay savings program for Jatenzo. Eligible commercially insured patients in Georgia can use the card to reduce their out-of-pocket cost to as low as $0 per fill, subject to a monthly maximum benefit and an annual cap that Tolmar adjusts periodically. [7]

Key eligibility rules as of 2026:

1. The patient must have commercial (private) insurance. Patients covered by any federal or state government program, including Georgia Medicaid, Medicare, TRICARE, or VA benefits, are not eligible.
2. The savings card does not apply to cash-pay patients; it offsets the co-pay or co-insurance after insurance processes the claim.
3. Enrollment is completed at JatenzoSavings.com or by calling the Tolmar patient support line. The prescriber's NPI and the dispensing pharmacy's NCPDP number are required at enrollment.
4. The card is accepted at most major retail pharmacy chains in Georgia. Some independent and specialty pharmacies may not be enrolled in the program; verify before dispensing.

Patients who are uninsured or whose insurance explicitly excludes testosterone products will not benefit from the savings card and should evaluate the compounded testosterone undecanoate option discussed below.

A 2022 analysis published in Health Affairs found that manufacturer co-pay cards increase branded drug adherence by 19 to 28% compared with patients facing full co-pay exposure, but they also reduce the incentive to switch to lower-cost alternatives. [8] Clinicians should weigh whether the savings card makes Jatenzo genuinely affordable long-term versus compounding for cash-pay patients.

Is Compounded Oral Testosterone Undecanoate Legal in Georgia?

Yes. Licensed 503A compounding pharmacies in Georgia may legally prepare oral testosterone undecanoate capsules for individual patients when a valid, patient-specific prescription is presented by a licensed prescriber. [9] Section 503A of the Federal Food, Drug, and Cosmetic Act allows state-licensed pharmacies to compound drugs not commercially available in the needed dose or form, or when a prescriber documents a specific patient need that the commercial product cannot meet.

Testosterone undecanoate appears on FDA's list of bulk drug substances that may be used in compounding under 503A without being subject to the "essentially a copy" restriction, provided the compounding pharmacy can document a legitimate patient-specific clinical reason. [10] Georgia's State Board of Pharmacy enforces both federal 503A requirements and Georgia-specific compounding standards (Georgia Code Title 26, Chapter 4).

Cost at Georgia 503A pharmacies varies but is commonly reported in the $50 to $200 per month range depending on the dose and the pharmacy's pricing structure. That gap relative to the $900 list price of branded Jatenzo is substantial and is the primary driver of patient interest in compounded formulations.

One meaningful clinical caveat: compounded oral testosterone undecanoate formulations have not undergone the bioequivalence or bioavailability testing required for FDA approval. The absorption of oral testosterone undecanoate is highly dependent on the lipid vehicle and the specific excipient profile of the capsule. Swerdloff et al. specifically noted that Jatenzo's proprietary oleic acid-based formulation was central to achieving consistent lymphatic absorption. [2] A compounded capsule using a different oil base may produce different peak and trough testosterone concentrations. Monitoring serum testosterone two to eight hours after the morning dose is therefore especially important when using a compounded product.

The HealthRX clinical team recommends a four-point monitoring protocol for patients starting compounded oral testosterone undecanoate in Georgia:

1. Baseline morning testosterone (drawn before 10:00 a.m.) plus hematocrit, PSA, and blood pressure before the first dose.
2. Repeat serum testosterone two to eight hours after the morning dose at week four, targeting 400 to 700 ng/dL.
3. Blood pressure check at week four and week twelve (Jatenzo's FDA label documents a mean systolic increase of 3 to 5 mmHg in clinical trials [3]).
4. Hematocrit at three months and six months; hold dose if hematocrit exceeds 54%, per the Endocrine Society guideline. [1]

This framework applies equally to branded Jatenzo and compounded oral TU.

Can You Get Jatenzo via Telehealth in Georgia?

Telehealth prescribing of Jatenzo is legal in Georgia. Testosterone is a Schedule III controlled substance under the Controlled Substances Act. [11] The DEA's 2023 proposed telemedicine rules, and the subsequent 2024 temporary extension, permit prescribing of Schedule III non-narcotic substances via telemedicine when a valid patient-prescriber relationship is established, which in practice means a synchronous audio-visual encounter and a complete clinical evaluation including review of laboratory results.

Georgia does not impose additional state-specific restrictions beyond federal DEA requirements for Schedule III telemedicine prescribing as of 2026. The prescriber must hold a Georgia state medical license and a DEA registration that includes Georgia as a state of authorization.

For practical purposes, a Georgia patient can complete a testosterone evaluation entirely via telehealth if the following are in place:

• Lab work (morning testosterone, LH, FSH, hematocrit, PSA in men over 40) drawn at a local lab prior to the telehealth visit
• A synchronous video visit with the prescriber (audio-only does not meet DEA standards for Schedule III prescribing under current rules)
• An e-prescription sent to a Georgia-licensed pharmacy or a DEA-registered mail-order pharmacy that ships to Georgia

The American Telemedicine Association's 2024 clinical standards note that "laboratory confirmation of the clinical diagnosis prior to initiating controlled substance therapy via telemedicine is the minimum acceptable standard of care." [12] HealthRX clinicians require two confirmed testosterone values before initiating any testosterone therapy, whether delivered in person or via telehealth.

Telehealth does not reduce the cost of Jatenzo itself. The $900 list price applies regardless of how the prescription is generated. However, telehealth platforms that include compounding pharmacy partnerships may offer bundled compounded testosterone programs at a lower total cost than branded Jatenzo through a traditional pharmacy.

Why Is Jatenzo So Expensive and Will the Price Drop?

Jatenzo received FDA approval in March 2019. [3] It holds market exclusivity as the first oral testosterone undecanoate approved in the United States. No generic has been approved because no ANDA (Abbreviated New Drug Application) referencing Jatenzo as a reference listed drug has cleared FDA review as of early 2026. The branded price of $900 per month reflects both development cost recovery and absence of generic competition.

Andriol, the oral testosterone undecanoate formulation used in Europe and Canada for decades, has a different excipient profile and was never submitted for FDA approval, so it does not represent a direct generic pathway for U.S. patients.

Patent expiry and generic entry timelines for Jatenzo are not publicly confirmed for 2026 or 2027. Until a generic enters the U.S. market, the list price is unlikely to fall significantly. Patients without adequate insurance coverage should evaluate the compounded option or request a letter of medical necessity for insurance tier exception.

A 2021 JAMA analysis of specialty drug pricing found that branded hormonal agents without generic competition maintained 95 to 99% of their launch price for a median of 6.4 years post-launch. [13] Jatenzo launched at roughly $900/month and has tracked that pattern.

Comparing Testosterone Therapy Costs in Georgia: Jatenzo vs. Alternatives

Jatenzo is one of the most expensive testosterone formulations available in Georgia. The cost comparison below uses 2026 cash-pay prices at Georgia pharmacies:

• Testosterone cypionate 200 mg/mL injection (generic, 10 mL vial): approximately $30 to $60 per vial, lasting two to ten weeks depending on dose frequency.
• Testosterone enanthate 200 mg/mL injection (generic): approximately $40 to $80 per vial.
• Testosterone gel 1% (AndroGel generic): approximately $60 to $120 per month.
• Testosterone 1.62% gel (authorized generic): approximately $80 to $150 per month.
• Natesto nasal testosterone gel: approximately $500 to $600 per month.
• Jatenzo 158 mg oral capsules (branded): approximately $900 per month.
• Compounded oral testosterone undecanoate (503A pharmacy): approximately $50 to $200 per month.

The Endocrine Society guideline acknowledges that injectable testosterone cypionate and enanthate are "equally effective" to newer formulations for achieving normal serum testosterone when dosed correctly, and recommends them as first-line options when cost is a barrier. [1] Jatenzo's oral route is a genuine clinical advantage for patients with needle aversion, bleeding disorders, or occupational restrictions on injections, but that advantage has a real dollar cost.

A 2020 Endocrine Practice study examining patient-reported testosterone therapy preferences found that 34% of hypogonadal men rated "oral administration" as their top delivery preference, while 41% prioritized cost below $100/month. [14] For that majority, compounded injectable or topical testosterone remains the more practical choice unless insurance or the savings card adequately offsets Jatenzo's price.

Georgia-Specific Patient Assistance Resources

Beyond the Tolmar savings card, Georgia patients have access to several additional resources:

NeedyMeds and RxAssist: These nonprofit databases list patient assistance programs (PAPs). Tolmar's PAP for Jatenzo provides free or reduced-cost medication to uninsured or underinsured patients who meet income eligibility criteria, typically at or below 400% of the federal poverty level. Applications require prescriber signature and proof of income. [15]

Georgia's Department of Community Health 340B program: Federally qualified health centers (FQHCs) and certain rural health clinics in Georgia participate in the 340B drug pricing program, which provides substantial discounts on outpatient drugs including some branded hormonal therapies. Patients who receive care at a 340B-covered entity may access Jatenzo at 340B pricing if the entity's formulary includes it. [16]

Georgia Prescription Assistance Program (Georgia Rx): The state-run program assists low-income Georgia residents who do not qualify for Medicaid. Eligibility is income-based and program availability changes annually; visit the Georgia Department of Community Health website for current enrollment status.

Manufacturer free trial programs: Tolmar has historically offered a limited free trial supply (30-day trial) through the prescriber's office for newly diagnosed patients. Availability varies and must be confirmed directly with the Tolmar sales representative or via the prescriber's office.

The CDC's National Diabetes Statistics Report (2022) reported that 11.6% of Georgia adults have diagnosed diabetes, the highest quartile nationally. [17] Because Georgia Medicaid covers Jatenzo only for type 2 diabetes, Georgia patients with both hypogonadism and type 2 diabetes have a plausible dual-indication pathway for Medicaid coverage that should be explored with the prescribing physician and a Medicaid prior authorization specialist.

Blood Pressure Monitoring Is Required by the FDA Label

Every Georgia patient filling Jatenzo must understand one non-negotiable safety requirement. The FDA prescribing information carries a boxed warning that Jatenzo can cause blood pressure increases that raise the risk of major adverse cardiovascular events. [3] The label states that Jatenzo is contraindicated in patients with hypertension that is not adequately controlled and requires blood pressure measurement before starting therapy and monitoring throughout treatment.

In the key trial (Swerdloff et al., N=166), mean systolic blood pressure increased by approximately 3 to 5 mmHg from baseline. [2] That magnitude may appear modest in isolation, but a meta-analysis published in The Lancet (2021, N=348,854) found that each 5 mmHg reduction in systolic blood pressure reduces the risk of major cardiovascular events by approximately 10%. [18] The inverse logic applies: a 5 mmHg increase carries a proportional risk increment.

Patients with baseline systolic blood pressure above 130 mmHg should have that pressure optimized before starting Jatenzo. The American Heart Association's 2017 hypertension guideline defines Stage 1 hypertension as systolic 130 to 139 mmHg, and Stage 2 as systolic 140 mmHg or higher. [19] Starting Jatenzo in a patient at Stage 2 without concurrent antihypertensive therapy is inconsistent with the FDA label.

Georgia telehealth patients should confirm that their remote prescriber has reviewed recent blood pressure readings, not just laboratory values, before the Jatenzo prescription is sent.

Step-by-Step: Getting Jatenzo or Compounded Oral TU in Georgia in 2026

1. Order morning labs (testosterone total, LH, FSH, hematocrit, PSA if male over 40, and a baseline blood pressure reading) at a Georgia LabCorp, Quest, or Labcorp/DCH facility.
2. Schedule a clinical evaluation with a Georgia-licensed physician, PA, or NP, either in person or via synchronous video telehealth.
3. Confirm diagnosis: two testosterone values below 300 ng/dL on separate mornings are the minimum standard.
4. Discuss formulary status with your insurance. Request a prior authorization if your plan covers Jatenzo. Ask for a letter of medical necessity template.
5. If commercially insured and the PA is approved, enroll in the Tolmar savings card to reduce co-pay.
6. If uninsured or Medicaid-covered for hypogonadism, ask the prescriber for a compounded oral testosterone undecanoate prescription at a Georgia-licensed 503A pharmacy.
7. At the four-week mark, draw a serum testosterone two to eight hours after your morning dose to confirm absorption and titrate if needed. [2]
8. Monitor blood pressure at every follow-up visit. Report any systolic reading above 140 mmHg to your prescriber immediately.

Georgia patients who complete those eight steps have met the clinical and regulatory requirements for safe, legal testosterone therapy with either the branded or compounded oral formulation. Your four-week serum testosterone result, drawn two to eight hours post-dose, is the single most useful data point for dose optimization.